首页 | 本学科首页   官方微博 | 高级检索  
检索        


Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease
Authors:Whitley W Aamodt MD  MPH  Teresa Waligorska MSc  Junchao Shen BS  Thomas F Tropea DO  MPH  MSTR  Andrew Siderowf MD  MSCE  Daniel Weintraub MD  Murray Grossman MD  David Irwin MD  MSTR  David A Wolk MD  Sharon X Xie PhD  John Q Trojanowski MD  PhD  Leslie M Shaw PhD  Alice S Chen-Plotkin MD
Institution:1. Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA;2. Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA;3. Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA;4. Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA;5. Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA;6. Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Abstract:
Keywords:neurofilament light chain protein  NfL  biomarkers  Parkinson's disease  prognosis
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号